Thermo Fisher Scientific Inc. (TMO)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$314M
Holdings value Q1 2024
$182B
Value change Q1 2024
-$4.67B
Grand Portfolio weight change Q1 2024
-0.01%
Number of holders
2526
Number of Buys Q1 2024
1111
Number of Sells Q1 2024
-1036
Average Buys Q1 2024 %
+0.104%
Average Sells Q1 2024 %
-0.022%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 314M $182B -$4.67B $581.21 2,487
2023 Q4 326M $173B +$1.29B $530.79 2,486
2023 Q3 333M $168B -$399M $506.17 2,367
2023 Q2 328M $171B -$206M $521.75 2,388
2023 Q1 325M $188B -$1.83B $576.37 2,362
2022 Q4 341M $188B +$1.52B $550.69 2,372
2022 Q3 340M $173B -$451M $507.19 2,253
2022 Q2 329M $179B +$1.03B $543.28 2,260
2022 Q1 335M $198B +$260M $590.65 2,307
2021 Q4 340M $227B +$253M $667.24 2,350
2021 Q3 331M $189B +$1.15B $571.33 2,144
2021 Q2 340M $171B -$409M $504.47 2,076
2021 Q1 341M $156B -$1.21B $456.38 2,044
2020 Q4 341M $159B -$1.45B $465.78 2,035
2020 Q3 351M $155B -$51.4M $441.52 1,856
2020 Q2 351M $127B +$805M $362.34 1,746
2020 Q1 348M $98.9B -$685M $283.60 1,668
2019 Q4 347M $113B -$786M $324.87 1,683
2019 Q3 357M $104B +$695M $291.27 1,562
2019 Q2 356M $104B +$2.53B $293.68 1,570
2019 Q1 343M $93.8B +$550M $273.72 1,529
2018 Q4 352M $78.8B -$125M $223.79 1,461
2018 Q3 352M $85.9B +$1.19B $244.08 1,367
2018 Q2 350M $72.4B +$1.09B $207.14 1,326
2018 Q1 348M $71.9B -$317M $206.46 1,323
2017 Q4 352M $66.9B +$668M $189.88 1,262
2017 Q3 350M $66.2B +$2.76B $189.20 1,183
2017 Q2 338M $58.9B -$108M $174.47 1,179
2017 Q1 343M $52.7B +$3.39B $153.60 1,150
2016 Q4 343M $48.5B -$23.9M $141.10 1,130
2016 Q3 346M $55B -$233M $159.06 1,055
2016 Q2 346M $51.1B +$179M $147.76 1,069
2016 Q1 347M $49.1B -$575M $141.59 1,034
2015 Q4 355M $50.4B +$417M $141.85 1,035
2015 Q3 357M $43.7B +$1.07B $122.28 984
2015 Q2 348M $45.2B -$47.3M $129.76 994
2015 Q1 357M $48B -$218M $134.34 986
2014 Q4 363M $45.5B +$629M $125.29 982
2014 Q3 362M $44.1B +$344M $121.70 938
2014 Q2 366M $43.1B +$902M $118.00 928
2014 Q1 362M $43.5B +$890M $120.24 939